Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: A quantitative analysis

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 2, 2011, Pages 489-497

  Mazzucchelli, R ^a   Scarpelli, M ^a   Lopez Beltran, A ^b   Cheng, L ^c   Bartels, H ^d   Bartels, P H ^d   Alberts, D S ^d   Montironi, Rodolfo ^a,d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Global DNA methylation; Global histone acetylation; Papillary urothelial neoplasm of low malignant potential; Recurrence; Urothelium

Indexed keywords

5 METHYLCYTOSINE; LYSINE; HISTONE;

ARTICLE; BASAL AMYGDALA; CONTROLLED STUDY; DNA METHYLATION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OPTICAL DENSITY; PAPILLARY CARCINOMA; PHOTOMETRY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; TRANSITIONAL CELL CARCINOMA; UROTHELIUM; ACETYLATION; CANCER INVASION; CHEMISTRY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEASIBILITY STUDY; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROTEIN PROCESSING; TUMOR RECURRENCE; URINARY TRACT CANCER; ADULT; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN TISSUE; MALE; MIDDLE AGED; PAPILLARY UROTHELIAL NEOPLASIA OF LOW MALIGNANT POTENTIAL;

5-METHYLCYTOSINE; ACETYLATION; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; FEASIBILITY STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; LYSINE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 80051756462     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400222     Document Type: Article

References (35)

1. Sauter G, Algaba F, Amin MB, et al. Tumours of the urinary system. In: Epstein JI, Eble JN, Sesterhenn I, Sauter G (eds) World Health Organization Classification of Tumours Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs. IARC Press. Lyon, 2004; p. 89-157.
2. Montironi R, Mazzucchelli R, Scarpelli M, LopezBeltran A, Cheng L. Morphological diagnosis of the urothelial neoplasms. J Clin Pathol 2008; 61:3-10. (Pubitemid 351158218)
3. Montironi R, Scarpelli M, Lopez-Beltran A, et al. Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential. Cell Oncol 2007; 29:47-58. (Pubitemid 46535190)
4. Herranz M, Esteller M. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol Biol 2007; 361:25-62. (Pubitemid 350183201)
5. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389: 251-60. (Pubitemid 27406632)
6. Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007; 99:908-15. (Pubitemid 46439577)
7. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997; 389:349-52. (Pubitemid 27415209)
8. Kurdistani SK, Tavazoie S, Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 2004;117:721-33. (Pubitemid 38748889)
9. Marino-Ramirez L, Kann MG, Shoemaker BA, Landsman D. Histone structure and nucleosome stability. Expert Rev Proteomics 2005; 2:719-29. (Pubitemid 41492393)
10. Orr JA, Hamilton PW. Histone acetylation and chromatin pattern in cancer. A review. Anal Quant Cytol Histol 2007; 29:17-31. (Pubitemid 46333518)
11. Turner BM. Histone acetylation as an epigenetic determinant of long-term transcriptional competence. Cell Mol Life Sci 1998; 54:21-31. (Pubitemid 28048247)
12. Bedford MT, Van Helden PD. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 1987; 47:5274-76. (Pubitemid 17152932)
13. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998; 7:531-36. (Pubitemid 28354117)
14. Galusca B, Dumollard JM, Lassandre S, Niveleau A, Prades JM, Estour B, Peoc'h M. Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia. Virchows Arch 2005; 447:18-23. (Pubitemid 41126236)
15. Hernandez-Blazquez FJ, Habib M, Dumollard JM, Barthelemy C, Benchaib M, De Capoa A, Niveleau A. Evaluation of global DNA hypomethylation in human colon cancer tissues by immunohistochemistry and image analysis. Gut 2000; 47:689-93.
16. Marte B. Cancer: a changing global view. Nature 2005; 435:1172. (Pubitemid 40943072)
17. Piyathilake CJ, Bell WC, Jones J, Henao OL, Heimburger DC, Niveleau A, Grizzle WE. Patterns of global DNA and histone methylation appear to be similar in normal, dysplastic and neoplastic oral epithelium of humans. Dis Markers 2005; 21:147-51. (Pubitemid 41566733)
18. Piyathilake CJ, Frost AR, Bell WC, Oelschlager D, Weiss H, Johanning GL, Niveleau A, Heimburger DC, Grizzle WE. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum Pathol 2001; 32:856-62. (Pubitemid 32803988)
19. Piyathilake CJ, Henao O, Frost AR, Macaluso M, Bell WC, Johanning GL, Heimburger DC, Niveleau A, Grizzle WE. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control 2003; 14:37-42. (Pubitemid 36403267)
20. Piyathilake CJ, Johanning GL. Cellular vitamins, DNA methylation and cancer risk. J Nutr 2002; 132: 2340S-3818.
21. Piyathilake CJ, Johanning GL, Frost AR, Whiteside MA, Manne U, Grizzle WE, Heimburger DC, Niveleau A. Immunohistochemical evaluation of global DNA methylation: comparison with in vitro radiolabeled methyl incorporation assay. Biotech Histochem 2000; 75:251-58.
22. Qian DZ, Wei YF, Wang X, Kato Y, Cheng L, Pili R. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models. Prostate 2007; 67:1182-93. (Pubitemid 47221885)
23. Rougier N, Bourchis D, Gomes DM, Niveleau A, Plachot M, Paldi A, Viegas-Pequignot E. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev 1998; 12:2108-13. (Pubitemid 28348034)
24. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435:1262-66. (Pubitemid 40943093)
25. Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624-29.
26. Sasco AJ, Rey F, Reynaud C, Bobin JY, Clavel M, Niveleau A. Breast cancer prognostic significance of some modified urinary nucleosides. Cancer Lett 1996; 108:157-62. (Pubitemid 26420133)
27. Barbisan F, Mazzucchelli R, Santinelli A, Stramazzotti D, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential. Int J Immunopathol Pharmacol 2008; 21:615-23.
28. Montironi R, Scarpelli M, Lopez-Beltran A, et al. Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential. Cell Oncol 2007; 29:47-58. (Pubitemid 46535190)
29. Rundlett SE, Carmen AA, Suka N, Turner BM, Grunstein M. Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature 1998; 392:831-35. (Pubitemid 28225326)
30. Vogelauer M, Wu J, Suka N, Grunstein M. Global histone acetylation and deacetylation in yeast. Nature 2000; 408:495-98.
31. Kurdistani SK. Histone modifications as markers of cancer prognosis: a cellular view. Br J Cancer 2007; 97:1-5. (Pubitemid 47012099)
32. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4:143-53. (Pubitemid 38198742)
33. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31:89-97. (Pubitemid 43221841)
34. Gama-Sosa MA, Wang RY, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of highly repeated sequences in human DNA. Nucleic Acids Res 1983; 11:3087-95.
35. Hakkarainen M, Wahlfors J, Myöhänen S, Hiltunen MO, Eskelinen M, Johansson R, Jänne J. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing. Int J Cancer 1996; 69:471-74. (Pubitemid 27050524)